Table 2.
Time trends in age-standardized and age-specific colorectal, colon and rectal cancer incidence rates for the total population and according to site, age at diagnosis & stage
| Population | Stage | Annual Incidence Rate per 100,000 During Early Screening Phase (2003-2005) | Most Recent Annual Incidence Rate per 100,000 (2015-2017) | Absolute Difference in Rates | Relative Difference in Rates (%) | APC | 95% CI |
|---|---|---|---|---|---|---|---|
| Colorectal Cancer (C18-C20) | |||||||
| Total Population | All Stages | 41.9 | 34.9 | -7.0 | -16.7% | 2003-2007: 0.4% | [-1; 1.8] |
| 2007-2017: -2.2% | [-2.5; -1.8] | ||||||
| Early Stage | 17.4 | 15.3 | -2.0 | -11.7% | 2003-2017: -1% | [-1.3; -0.7] | |
| Late Stage | 24.5 | 19.6 | -5.0 | -20.2% | 2003-2006: 1.9% | [-1; 4.8] | |
| 2006-2017: -2.7% | [-3; -2.3] | ||||||
| 15-34 Years | All Stages | 0.9 | 1.4 | 0.6 | 65.7% | 2003-2017: 4.3% | [3.3; 5.3] |
| Early Stage | 0.3 | 0.5 | 0.2 | 77.6% | 2003-2017: 5.7% | [3; 8.5] | |
| Late Stage | 0.6 | 0.9 | 0.3 | 59.5% | 2003-2017: 3.6% | [2.2; 5] | |
| 35-39 Years | All Stages | 4.7 | 5.2 | 0.5 | 10.1% | 2003-2017: 1.4% | [0.2; 2.6] |
| Early Stage | 1.5 | 1.8 | 0.3 | 20.5% | 2003-2017: 2.4% | [0.5; 4.4] | |
| Late Stage | 3.2 | 3.4 | 0.2 | 5.5% | 2003-2017: 0.8% | [-0.7; 2.4] | |
| 40-49 Years | All Stages | 14.7 | 16.2 | 1.5 | 10.2% | 2003-2017: 0.7% | [0; 1.3] |
| Early Stage | 5.7 | 6.1 | 0.4 | 7.7% | 2003-2017: 0.8% | [0.1; 1.5] | |
| Late Stage | 9.0 | 10.1 | 1.0 | 11.8% | 2003-2017: 0.6% | [-0.3; 1.5] | |
| 50-54 Years | All Stages | 42.4 | 39.6 | -2.8 | -6.5% | 2003-2008: 1.5% | [0.3; 2.7] |
| 2008-2012: -3.8% | [-6.4; -1.2] | ||||||
| 2012-2017: 0.8% | [-0.4; 2] | ||||||
| Early Stage | 15.7 | 15.9 | 0.2 | 1.3% | 2003-2017: -0.1% | [-0.9; 0.7] | |
| Late Stage | 26.6 | 23.7 | -2.9 | -11.1% | 2003-2008: 1.5% | [-0.9; 4] | |
| 2008-2012: -5.3% | [-10.3; -0.1] | ||||||
| 2012-2015: 2.9% | [-7.6; 14.6] | ||||||
| 2015-2017: -4% | [-13.9; 6.9] | ||||||
| 55-69 Years | All Stages | 129.3 | 95.7 | -33.6 | -26.0% | 2003-2008: -1.3% | [-2; -0.5] |
| 2008-2011: -4.6% | [-7.7; -1.3] | ||||||
| 2011-2017: -2.2% | [-2.8; -1.7] | ||||||
| Early Stage | 54.7 | 40.4 | 0.2 | 77.6% | 2003-2017: -2.6% | [-2.9; -2.2] | |
| Late Stage | 74.6 | 55.3 | 0.3 | 59.5% | 2003-2006: -0.1% | [-3.6; 3.5] | |
| 2006-2017: -3.1% | [-3.6; -2.6] | ||||||
| 70+ Years | All Stages | 262.5 | 222.2 | -40.2 | -15.3% | 2003-2007: 1.5% | [-0.3; 3.3] |
| 2007-2017: -2.3% | [-2.7; -1.8] | ||||||
| Early Stage | 109.8 | 106.4 | 0.3 | 20.5% | 2003-2007: 1.7% | [-0.9; 4.3] | |
| 2007-2017: -0.9% | [-1.5; -0.2] | ||||||
| Late Stage | 152.7 | 115.9 | 0.2 | 5.5% | 2003-2005: 3.6% | [-1.5; 9] | |
| 2005-2008: -1% | [-5.9; 4.2] | ||||||
| 2008-2017: -3.5% | [-3.9; -3] | ||||||
| Colon Cancer (C18) | |||||||
| Total Population | All Stages | 25.8 | 21.7 | -4.1 | -15.9% | 2003-2007: 0.1% | [-1.6; 1.8] |
| 2007-2017: -2% | [-2.4; -1.6] | ||||||
| Early Stage | 10.8 | 10.2 | -0.5 | -5.0% | 2003-2017: -0.4% | [-0.8; -0.1] | |
| Late Stage | 15.0 | 11.5 | -3.6 | -23.7% | 2003-2006: 0.9% | [-1.9; 3.8] | |
| 2006-2017: -2.9% | [-3.3; -2.6] | ||||||
| 15-34 Years | All Stages | 0.5 | 0.8 | 0.3 | 47.8% | 2003-2017: 3.3% | [2.1; 4.5] |
| Early Stage | 0.2 | 0.3 | 0.1 | 52.6% | 2003-2017: 4.2% | [0.7; 7.8] | |
| Late Stage | 0.4 | 0.5 | 0.2 | 44.6% | 2003-2017: 2.7% | [0.9; 4.6] | |
| 35-39 Years | All Stages | 2.9 | 2.6 | -0.3 | -10.2% | 2003-2017: 0.3% | [-1.7; 2.5] |
| Early Stage | 0.9 | 0.9 | 0.0 | 2.6% | 2003-2017: 0.3% | [-1.7; 2.5] | |
| Late Stage | 2.0 | 1.7 | -0.3 | -15.7% | 2003-2017: -0.6% | [-2.6; 1.5] | |
| 40-49 Years | All Stages | 7.9 | 8.7 | 0.9 | 10.9% | 2003-2017: 0.6% | [-0.1; 1.4] |
| Early Stage | 3.1 | 3.5 | 0.4 | 13.9% | 2003-2017: 1.1% | [0.3; 2] | |
| Late Stage | 4.8 | 5.2 | 0.4 | 9.3% | 2003-2017: 0.3% | [-0.9; 1.4] | |
| 50-54 Years | All Stages | 22.5 | 21.3 | -1.3 | -5.7% | 2003-2009: 0.8% | [-0.5; 2] |
| 2009-2012: -6.3% | [-12.9; 0.8] | ||||||
| 2012-2017: 2.7% | [1.1; 4.4] | ||||||
| Early Stage | 8.4 | 9.6 | 1.2 | 13.9% | 2003-2005: -6.9% | [-20.1; 8.4] | |
| 2005-2008: 7.9% | [-7.3; 25.7] | ||||||
| 2008-2015: -2.5% | [-5; 0.1] | ||||||
| 2015-2017: 15.7% | [-0.6; 34.8] | ||||||
| Late Stage | 14.2 | 11.7 | -2.4 | -17.2% | 2003-2008: 0.6% | [-3.2; 4.5] | |
| 2008-2012: -7.1% | [-14.8; 1.2] | ||||||
| 2012-2015: 5.6% | [-11; 25.3] | ||||||
| 2015-2017: -6.2% | [-20.9; 11.4] | ||||||
| 55-69 Years | All Stages | 75.7 | 56.0 | -19.7 | -26.0% | 2003-2008: -1.6% | [-2.7; -0.5] |
| 2008-2011: -4.5% | [-9.1; 0.4] | ||||||
| 2011-2017: -2% | [-2.9; -1.2] | ||||||
| Early Stage | 32.4 | 25.6 | 0.4 | 13.9% | 2003-2017: -2% | [-2.3; -1.7] | |
| Late Stage | 43.3 | 30.4 | 0.4 | 9.3% | 2003-2006: -0.5% | [-3.6; 2.7] | |
| 2006-2012: -4.3% | [-5.7; -3] | ||||||
| 2012-2017: -2.1% | [-3.5; -0.7] | ||||||
| 70+ Years | All Stages | 178.8 | 155.1 | -23.6 | -13.2% | 2003-2006: 2.3% | [-1.1; 5.9] |
| 2006-2017: -1.8% | [-2.3; -1.4] | ||||||
| Early Stage | 74.9 | 77.6 | 0.4 | 13.9% | 2003-2006: 2.5% | [-1.8; 7] | |
| 2006-2017: -0.1% | [-0.7; 0.5] | ||||||
| Late Stage | 103.8 | 77.5 | 0.4 | 9.3% | 2003-2006: 2.4% | [-1.1; 6] | |
| 2006-2017: -3.3% | [-3.8; -2.9] | ||||||
| Rectal Cancer (C19/C20) | |||||||
| Total Population | All Stages | 16.1 | 13.2 | -2.9 | -18.0% | 2003-2007: 1% | [-0.8; 2.8] |
| 2007-2017: -2.5% | [-2.9; -2.1] | ||||||
| Early Stage | 6.6 | 5.1 | -1.5 | -22.7% | 2003-2017: -2.1% | [-2.5; -1.7] | |
| Late Stage | 9.5 | 8.1 | -1.4 | -14.8% | 2003-2008: 1.3% | [-0.2; 2.7] | |
| 2008-2017: -2.7% | [-3.2; -2.1] | ||||||
| 15-34 Years | All Stages | 0.3 | 0.6 | 0.3 | 97.1% | 2003-2017: 5.9% | [4.4; 7.5] |
| Early Stage | 0.1 | 0.2 | 0.1 | 121.9% | 2003-2017: 7.6% | [4.4; 10.9] | |
| Late Stage | 0.2 | 0.4 | 0.2 | 84.5% | 2003-2017: 5% | [3; 7.1] | |
| 35-39 Years | All Stages | 1.9 | 2.6 | 0.8 | 41.5% | 2003-2017: 2.7% | [0.7; 4.7] |
| Early Stage | 0.6 | 0.9 | 0.3 | 46.4% | 2003-2017: 2.7% | [0.7; 4.7] | |
| Late Stage | 1.3 | 1.7 | 0.5 | 39.1% | 2003-2017: 2.8% | [0.9; 4.7] | |
| 40-49 Years | All Stages | 6.8 | 7.5 | 0.6 | 9.2% | 2003-2017: 0.7% | [0; 1.4] |
| Early Stage | 2.6 | 2.6 | 0.0 | 0.4% | 2003-2017: 0.4% | [-0.5; 1.3] | |
| Late Stage | 4.3 | 4.9 | 0.6 | 14.5% | 2003-2017: 0.9% | [-0.1; 1.9] | |
| 50-54 Years | All Stages | 19.8 | 18.4 | -1.5 | -7.5% | 2003-2007: 2.2% | [-0.7; 5.1] |
| 2007-2017: -1.7% | [-2.4; -1] | ||||||
| Early Stage | 7.3 | 6.4 | -1.0 | -13.2% | 2003-2017: -1.1% | [-2; -0.2] | |
| Late Stage | 12.5 | 12.0 | -0.5 | -4.2% | 2003-2017: -0.7% | [-1.5; 0] | |
| 55-69 Years | All Stages | 53.7 | 39.7 | -13.9 | -26.0% | 2003-2007: -0.7% | [-2.9; 1.6] |
| 2007-2017: -3.2% | [-3.7; -2.6] | ||||||
| Early Stage | 22.3 | 14.8 | 0.0 | 0.4% | 2003-2017: -3.4% | [-3.9; -2.9] | |
| Late Stage | 31.4 | 24.9 | 0.6 | 14.5% | 2003-2007: 0.7% | [-1.9; 3.4] | |
| 2007-2017: -2.9% | [-3.5; -2.3] | ||||||
| 70+ Years | All Stages | 83.7 | 67.1 | -16.6 | -19.9% | 2003-2008: 1.2% | [-0.3; 2.7] |
| 2008-2017: -3.3% | [-3.8; -2.7] | ||||||
| Early Stage | 34.9 | 28.7 | 0.0 | 0.4% | 2003-2007: 1.5% | [-1.6; 4.8] | |
| 2007-2017: -2.5% | [-3.3; -1.8] | ||||||
| Late Stage | 48.8 | 38.4 | 0.6 | 14.5% | 2003-2008: 1.6% | [-0.1; 3.3] | |
| 2008-2017: -3.7% | [-4.3; -3] | ||||||
Age-standardized and age-specific incidence rates = Cases per 100,000;
Incidence Rates for the Total Population are given as age-standardized rate using the European Standard (1976);
Early Stage = UICC (Union for International Cancer Control) I & II, Late Stage = UICC III & IV;
APC = Annual percent changes;
CI = Confidence interval